藏药二十五味珊瑚丸的文献计量学研究  

Literature review on Ershiwuwei-Shanhu pill

作　　者：韩亚南[1] 汪娟[1] 角加才仁 董楠楠 鲍先洁 Han Yanan;Wang Juan;Jiaojiacairen;Dong Nannan;Bao Xianjie(Research and Teaching Department, Beo＇ing Tibetan Hospital, China Tibatology Research Center, Beijing 100029, China)

机构地区：[1]中国藏学研究中心北京藏医院科教处,100029 [2]中国藏学研究中心北京藏医院药剂科,100029

出　　处：《国际中医中药杂志》2018年第5期423-426,共4页International Journal of Traditional Chinese Medicine

摘　　要：目的分析藏药二十五味珊瑚丸现代研究的相关文献，总结和归纳该药的科研现状。方法检索中国期刊全文数据库（CNKI）、万方科技数据库、维普数据库（VIP）建库至2017年9月15日，明确涉及二十五味珊瑚丸或本药其他剂型的相关研究，提取文献类型、发表时间、发表期刊、作者单位、基金资助情况、剂型、所治疾病、用药方式等信息，用Excel建立数据库，进行频数统计与内容分析。结果共纳入文献58篇，其中临床研究33篇、药理研究9篇、药学研究14篇、综述2篇；文献发表期刊39种，其中复合影响因子≥0．15的期刊占81．O％，2014年版北京大学《中文核心期刊要目总览》来源期刊7种。结论目前对于二十五味珊瑚丸的研究主要集中于临床研究方面，药理和药学研究略显薄弱。Objective To identify the scientific research status of Ershiwuwei-Shanhu pill among the literature review. Methods The literature were retrieved from CNKI, Wanfang and VIP databases （from databases built up to 2017）, and quantitative analysis was carried out in the fields of time, journals and types of literature published. Results There were 58 literatures, including 33 clinical studies, 9 pharmacological studies, 14 pharmacological studies and 2 reviews. The literature published 39 kinds of journals, among which there were 81.0% studies published in the journals holding the impact factors more and equal to 0.15 and 7 were core journals. Conclusions The results showed that the Ershiwuwei-Shanhu pill was in the developing period, mainly focused on clinical research, although there are some studies on pharmacology and pharmacy.The study of the ancient Tibetan medicine to the mature period there is still much space for development.

关 键 词：二十五味珊瑚丸 藏药 现代文献研究 文献计量学 

分 类 号：R29[医药卫生—民族医学]